The FDA proposed a rule today that would amend regulations regarding the classification of products as biological products, devices, drugs or combination products.
The agency said it hopes to modernize the regulations that surround the classification and assignment of medical products to individual centers for review – including drug-device combination products.
Get the full story at our sister site, Drug Delivery Business News.